In accordance with this research, our study showed the NR treatment reduced aggregated mutant hSOD1 proteins in the brain of SOD1G93A mice, which indicted that NAD+ salvage pathway was a potential therapeutic target suppressing the collection of misfolded SOD1 in the ALS. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.